Medicare fraud
Medicare fraud claims against Barton Associates fall short
The court said the relators described a suspicious setup, but not enough about the actual claims they say were billed. That kept the False Claims Act case from moving into discovery.
A federal appeals court ruled that the whistleblowers did not meet the fraud pleading rules. The result leaves the Barton Associates allegations unproven and the case dismissed.
- The First Circuit said the complaint lacked the detail fraud rules require.
- The case was a whistleblower lawsuit under the False Claims Act.
- Judges said the alleged Medicare scheme was too general to support the claims.
- The complaint alleged Barton Associates helped route patients and prescriptions through outside clients.
- The ruling leaves the fraud allegations unproven.
In the federal First Circuit, Reynaldo Solano and Neals Maxilin lost their attempt to revive a whistleblower lawsuit against Barton Associates, Inc. The court said their complaint did not describe the alleged fraud with enough detail to meet the rules that apply to False Claims Act cases.
That matters for people who depend on Medicare and other government health programs because the ruling kept the case from moving into evidence gathering. The judges did not decide whether Barton actually ran a fraud scheme. They said the allegations were too thin to support the claim in court.
What the whistleblowers claimed
Solano and Maxilin brought the case as a qui tam action, a type of whistleblower lawsuit that lets private plaintiffs sue on the government’s behalf. They said Barton, a staffing company that places medical professionals in temporary jobs, helped set up a process that led to false claims being submitted to Medicare and other government benefit programs.
According to the complaint, Barton encouraged clients to create call centers, sent patients to Barton physicians, and collected an added assessment fee for each prescription those physicians wrote. The complaint also said several companies, including Medtech Worldwide, RealTime Physicians, Ocenture and CareLumina, used Barton doctors to generate prescriptions for tests, equipment and medications that were then billed to the government.
Why the court said the case came up short
The court focused on Federal Rule of Civil Procedure 9(b), which requires fraud claims to be pleaded with particular detail. In plain terms, a plaintiff has to do more than describe a suspicious setup. The complaint must give a clear picture of who did what, when, where and how the alleged fraud worked.
The judges said Solano and Maxilin did not provide enough specifics about the supposed false claims themselves. They pointed to missing details about timing, locations, amounts and the government programs involved. They also said the complaint did not connect the alleged scheme closely enough to actual claims submitted for payment.
The First Circuit also upheld the lower court’s refusal to reopen the case or let the whistleblowers revise their complaint. The result leaves the allegations unresolved and unproven, but it underscores how often False Claims Act cases turn on the strength of the pleading before they ever reach the merits.
The bigger takeaway
False Claims Act cases can be powerful tools against healthcare fraud, but they face a high bar at the start. Courts want enough detail to show that a real fraud claim is being made, not just a theory that something improper may have happened.
Here, the judges said that bar was not met. For Barton Associates, that meant the case stayed dismissed. For whistleblowers and public health programs, it is another reminder that a detailed complaint can be just as important as the underlying accusation.